Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids – Toxicity testing in a 3D cell culture approach

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

Organisationseinheiten

Externe Organisationen

  • Zagazig University
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)10-19
Seitenumfang10
FachzeitschriftToxicology in vitro
Jahrgang53
PublikationsstatusVeröffentlicht - 23 Juli 2018

Abstract

The administration of immunosuppressive drugs is a necessary therapeutic measure in organ transplantation to prevent rejections. However, the use of temporarily high dosed immunosuppressive drugs is associated with cytotoxicity and adverse side effects that could induce endothelial dysfunction. The aim of this work is to evaluate the effect of the administrated drugs tacrolimus and mycophenolic acid (MPA) on human umbilical vein endothelial cells (HUVECs). Whereas MPA showed no significant toxicity in a dose-dependent manner, a dose-response curve of tacrolimus treatment could be obtained in 2D monolayer. Due to limited cell-cell and cell-extracellular matrix (ECM) interactions in 2D monolayers, 3D spheroids have been established. The comparison of IC50 values demonstrated that tacrolimus is more toxic towards endothelial cells in 3D spheroids (IC50 value = 27.19 μg/ml) than in 2D monolayers (IC50 value = 40.23 μg/ml). Moreover, the maximal trough level of tacrolimus achieved in immunosuppressive therapy (18 ng/ml) resulted in low disaggregation of the spheroids and decreased vessel areas with increased number of end points of tubular-like structures in the angiogenesis assay even if no toxic effect could be detected. Thus, our approach unseals very sensitive cytotoxic effects of tacrolimus on the vasculature in organ recipients after immunosuppressive therapy.

ASJC Scopus Sachgebiete

  • Pharmakologie, Toxikologie und Pharmazie (insg.)
  • Toxikologie

Zitieren

Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids – Toxicity testing in a 3D cell culture approach. / Thoms, Stefanie; Ali, Alaa Ibrahim; Jonczyk, Rebecca et al.
in: Toxicology in vitro, Jahrgang 53, 23.07.2018, S. 10-19.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Download
@article{5c6f05cd72d94397841572c8793d2ce8,
title = "Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids – Toxicity testing in a 3D cell culture approach",
abstract = "The administration of immunosuppressive drugs is a necessary therapeutic measure in organ transplantation to prevent rejections. However, the use of temporarily high dosed immunosuppressive drugs is associated with cytotoxicity and adverse side effects that could induce endothelial dysfunction. The aim of this work is to evaluate the effect of the administrated drugs tacrolimus and mycophenolic acid (MPA) on human umbilical vein endothelial cells (HUVECs). Whereas MPA showed no significant toxicity in a dose-dependent manner, a dose-response curve of tacrolimus treatment could be obtained in 2D monolayer. Due to limited cell-cell and cell-extracellular matrix (ECM) interactions in 2D monolayers, 3D spheroids have been established. The comparison of IC50 values demonstrated that tacrolimus is more toxic towards endothelial cells in 3D spheroids (IC50 value = 27.19 μg/ml) than in 2D monolayers (IC50 value = 40.23 μg/ml). Moreover, the maximal trough level of tacrolimus achieved in immunosuppressive therapy (18 ng/ml) resulted in low disaggregation of the spheroids and decreased vessel areas with increased number of end points of tubular-like structures in the angiogenesis assay even if no toxic effect could be detected. Thus, our approach unseals very sensitive cytotoxic effects of tacrolimus on the vasculature in organ recipients after immunosuppressive therapy.",
keywords = "3D, Angiogenesis, Endothelial cells, Spheroids, Tacrolimus, Toxicity",
author = "Stefanie Thoms and Ali, {Alaa Ibrahim} and Rebecca Jonczyk and Thomas Scheper and Cornelia Blume",
note = "Funding information: This work has been carried out as an integral part of the BIOFABRICATION FOR NIFE initiative ZN3228/ZN3267 , which is financially supported by the Ministry of Lower Saxony and the VolkswagenStiftung .",
year = "2018",
month = jul,
day = "23",
doi = "10.1016/j.tiv.2018.07.017",
language = "English",
volume = "53",
pages = "10--19",
journal = "Toxicology in vitro",
issn = "0887-2333",
publisher = "Elsevier Ltd.",

}

Download

TY - JOUR

T1 - Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids – Toxicity testing in a 3D cell culture approach

AU - Thoms, Stefanie

AU - Ali, Alaa Ibrahim

AU - Jonczyk, Rebecca

AU - Scheper, Thomas

AU - Blume, Cornelia

N1 - Funding information: This work has been carried out as an integral part of the BIOFABRICATION FOR NIFE initiative ZN3228/ZN3267 , which is financially supported by the Ministry of Lower Saxony and the VolkswagenStiftung .

PY - 2018/7/23

Y1 - 2018/7/23

N2 - The administration of immunosuppressive drugs is a necessary therapeutic measure in organ transplantation to prevent rejections. However, the use of temporarily high dosed immunosuppressive drugs is associated with cytotoxicity and adverse side effects that could induce endothelial dysfunction. The aim of this work is to evaluate the effect of the administrated drugs tacrolimus and mycophenolic acid (MPA) on human umbilical vein endothelial cells (HUVECs). Whereas MPA showed no significant toxicity in a dose-dependent manner, a dose-response curve of tacrolimus treatment could be obtained in 2D monolayer. Due to limited cell-cell and cell-extracellular matrix (ECM) interactions in 2D monolayers, 3D spheroids have been established. The comparison of IC50 values demonstrated that tacrolimus is more toxic towards endothelial cells in 3D spheroids (IC50 value = 27.19 μg/ml) than in 2D monolayers (IC50 value = 40.23 μg/ml). Moreover, the maximal trough level of tacrolimus achieved in immunosuppressive therapy (18 ng/ml) resulted in low disaggregation of the spheroids and decreased vessel areas with increased number of end points of tubular-like structures in the angiogenesis assay even if no toxic effect could be detected. Thus, our approach unseals very sensitive cytotoxic effects of tacrolimus on the vasculature in organ recipients after immunosuppressive therapy.

AB - The administration of immunosuppressive drugs is a necessary therapeutic measure in organ transplantation to prevent rejections. However, the use of temporarily high dosed immunosuppressive drugs is associated with cytotoxicity and adverse side effects that could induce endothelial dysfunction. The aim of this work is to evaluate the effect of the administrated drugs tacrolimus and mycophenolic acid (MPA) on human umbilical vein endothelial cells (HUVECs). Whereas MPA showed no significant toxicity in a dose-dependent manner, a dose-response curve of tacrolimus treatment could be obtained in 2D monolayer. Due to limited cell-cell and cell-extracellular matrix (ECM) interactions in 2D monolayers, 3D spheroids have been established. The comparison of IC50 values demonstrated that tacrolimus is more toxic towards endothelial cells in 3D spheroids (IC50 value = 27.19 μg/ml) than in 2D monolayers (IC50 value = 40.23 μg/ml). Moreover, the maximal trough level of tacrolimus achieved in immunosuppressive therapy (18 ng/ml) resulted in low disaggregation of the spheroids and decreased vessel areas with increased number of end points of tubular-like structures in the angiogenesis assay even if no toxic effect could be detected. Thus, our approach unseals very sensitive cytotoxic effects of tacrolimus on the vasculature in organ recipients after immunosuppressive therapy.

KW - 3D

KW - Angiogenesis

KW - Endothelial cells

KW - Spheroids

KW - Tacrolimus

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85050520355&partnerID=8YFLogxK

U2 - 10.1016/j.tiv.2018.07.017

DO - 10.1016/j.tiv.2018.07.017

M3 - Article

C2 - 30048735

AN - SCOPUS:85050520355

VL - 53

SP - 10

EP - 19

JO - Toxicology in vitro

JF - Toxicology in vitro

SN - 0887-2333

ER -

Von denselben Autoren